An evaluation of the effects of a topical traditional Chinese medicine formulation on muscle soreness associated with athletic training

Not Applicable

• Conditions: delayed muscle soreness related to exercise; Musculoskeletal - Other muscular and skeletal disorders; Alternative and Complementary Medicine - Herbal remedies

• Registration Number: ACTRN12619000843156
• Lead Sponsor: The University of Canberra

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-06-12
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 45

Inclusion Criteria

Participants recruited for this study will be:
1.Males aged between 18-35 years, who are physically active, but naive to eccentric contraction dominated movements.
2.Free from injuries or conditions that may make it unsafe to exercise (i.e. answers no to everything on the adult pre-exercise screening tool)
3.Agree to discontinue anti-inflammatory or analgesic medications (oral and topical) 3 days prior to starting the study (NSAIDs, Opioids or Steroids) or any complementary medicines with known anti-inflammatory properties, for example turmeric, glucosamine or high strength fish oils for the duration of the study.
4.Agree not to introduce any new personal care products such as physiotherapy, OTCs, topical or oral complementary medicine products, skin care, personal hygiene products during the study (due to investigation of adverse effects on skin, skin care and personal hygiene products is prohibited).
5.Agree to abstain for physical activity for up to 96 hours post eccentric exercise.

Exclusion Criteria

Participants will be excluded if they:
1.Regularly participate in strength training or long distance running (due to the eccentric contractions associated with these activities).
2.Allergy to CKPRO or any of its ingredients
3.Individuals with; broken or infected skin proximal or on the application site; skin affected by diabetes
4.Individuals who have participated in other clinical trials within 28 days prior starting of the study.
5.Individuals with medical conditions which anti-inflammatory or analgesic medications must be used.
6.Individuals who do not meet any of the inclusion criteria.

Study & Design

• Study Type: Interventional
• Study Design: Not specified